DK1261875T3 - Diagnostisk analyse for transmissibel spongiform encephalopati - Google Patents

Diagnostisk analyse for transmissibel spongiform encephalopati

Info

Publication number
DK1261875T3
DK1261875T3 DK01931527T DK01931527T DK1261875T3 DK 1261875 T3 DK1261875 T3 DK 1261875T3 DK 01931527 T DK01931527 T DK 01931527T DK 01931527 T DK01931527 T DK 01931527T DK 1261875 T3 DK1261875 T3 DK 1261875T3
Authority
DK
Denmark
Prior art keywords
fabp
ami
spongiform encephalopathy
diagnostic analysis
transmissible spongiform
Prior art date
Application number
DK01931527T
Other languages
English (en)
Inventor
Denis Francois Hochstrasser
Jean-Charles Sanchez
Catherine Gabrielle Zimmermann
Elisabeth Guillaume
Original Assignee
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005683A external-priority patent/GB2360089A/en
Application filed by Univ Geneve filed Critical Univ Geneve
Application granted granted Critical
Publication of DK1261875T3 publication Critical patent/DK1261875T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
DK01931527T 2000-03-10 2001-03-12 Diagnostisk analyse for transmissibel spongiform encephalopati DK1261875T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0005683A GB2360089A (en) 2000-03-10 2000-03-10 Diagnostic assay for transmisible spongiform encephalopathies
GB0006064A GB0006064D0 (en) 2000-03-10 2000-03-14 Diagnostic assay for transmissable spongiform encephalopathies
PCT/EP2001/002894 WO2001067108A2 (en) 2000-03-10 2001-03-12 Diagnostic assay for transmissible spongiform encephalopathies

Publications (1)

Publication Number Publication Date
DK1261875T3 true DK1261875T3 (da) 2007-11-26

Family

ID=26243824

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01931527T DK1261875T3 (da) 2000-03-10 2001-03-12 Diagnostisk analyse for transmissibel spongiform encephalopati

Country Status (9)

Country Link
US (1) US7368247B2 (da)
EP (1) EP1261875B1 (da)
JP (1) JP4575635B2 (da)
AT (1) ATE368858T1 (da)
AU (2) AU2001258282B2 (da)
CA (1) CA2402314C (da)
DE (1) DE60129674T2 (da)
DK (1) DK1261875T3 (da)
WO (1) WO2001067108A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
WO2003012445A1 (en) * 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US7655480B2 (en) * 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
US8450071B2 (en) 2002-03-08 2013-05-28 The Board Of Regents Of The University Of Oklahoma Biomarker and method for detecting a chronic inflammatory-associated disease
JP4498918B2 (ja) 2002-04-30 2010-07-07 生化学工業株式会社 リソソーム病の検出方法
EP1556702A2 (en) 2002-10-30 2005-07-27 Proteome Sciences Plc Diagnostic methods for transmissible spongiform encephalopathies (prion diseases)
EP2341350B1 (en) * 2003-09-20 2017-11-08 Electrophoretics Limited Diagnostic method for brain damage-related disorders based on detection of dj-1
CN100422742C (zh) * 2005-05-16 2008-10-01 艾博（武汉）生物技术有限公司 急性心肌梗死早期诊断三合一检测试剂板
GB2428240A (en) 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
US7399598B2 (en) * 2005-10-14 2008-07-15 Taipei Medical University Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
JP4965999B2 (ja) * 2005-12-27 2012-07-04 セント ルイス ユニバーシティ ムコ多糖症の診断方法
US7645616B2 (en) * 2006-10-20 2010-01-12 The University Of Hong Kong Use of lipocalin-2 as a diagnostic marker and therapeutic target
NL1033365C2 (nl) * 2007-02-09 2008-08-12 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
US9399675B2 (en) 2007-02-28 2016-07-26 The Board Of Regents Of The University Of Oklahoma Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
JP2008241387A (ja) * 2007-03-27 2008-10-09 Chube Univ メタボリックシンドロームの予知検査方法
NL2001577C2 (nl) * 2008-05-14 2009-11-17 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
KR101458100B1 (ko) * 2012-01-13 2014-11-05 가톨릭대학교 산학협력단 류마티스 관절염 진단 키트
RU2522231C1 (ru) * 2012-11-14 2014-07-10 Евгений Иосифович Гоуфман Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
WO2018048884A1 (en) * 2016-09-09 2018-03-15 Mayo Foundation For Medical Education And Research Methods and materials for identifying and treating autoimmune gfap astrocytopathy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3012666B2 (ja) * 1990-05-28 2000-02-28 大日本製薬株式会社 心筋梗塞の判定方法
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
GB2319607A (en) 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
EP0861900A1 (en) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
WO1998045440A1 (en) 1997-04-08 1998-10-15 Incyte Pharmaceuticals, Inc. Human fatty acid binding protein
FR2763692B1 (fr) * 1997-05-22 1999-07-09 Agronomique Inst Nat Rech Diagnostic in vitro des encephalopathies subaigues spongiformes transmissibles, par dosage de metabolites du cortisol
CA2206774A1 (en) * 1997-06-16 1998-12-16 Rick E. Preddie "prionins", highly specific markers for noninvasive presymptomatic defection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke

Also Published As

Publication number Publication date
CA2402314A1 (en) 2001-09-13
US7368247B2 (en) 2008-05-06
JP2003526788A (ja) 2003-09-09
WO2001067108A3 (en) 2002-03-21
AU2001258282B2 (en) 2005-05-05
US20030157580A1 (en) 2003-08-21
JP4575635B2 (ja) 2010-11-04
EP1261875A2 (en) 2002-12-04
WO2001067108A2 (en) 2001-09-13
CA2402314C (en) 2009-12-08
AU5828201A (en) 2001-09-17
DE60129674D1 (de) 2007-09-13
ATE368858T1 (de) 2007-08-15
EP1261875B1 (en) 2007-08-01
DE60129674T2 (de) 2008-06-05

Similar Documents

Publication Publication Date Title
DK1261875T3 (da) Diagnostisk analyse for transmissibel spongiform encephalopati
DE60034480D1 (de) Diagnostischer assay für schlaganfall
ATE300051T1 (de) Test zum nachweis von prionen-proteinen die in einer mit krankheit assoziierten konformationen vorliegen
Matsuo et al. Live‐Cell Protein Sulfonylation Based on Proximity‐driven N‐Sulfonyl Pyridone Chemistry
Wolenski et al. In vitro motility of immunoadsorbed brain myosin-V using a Limulus acrosomal process and optical tweezer-based assay
Uchida Aldehyde adducts generated during lipid peroxidation modification of proteins
ES2171705T3 (es) Complejos de polipeptido-dendrimero.
ATE360433T1 (de) Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose
DE10303974A1 (de) Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DE69833378D1 (de) Fluoreszierende polarisation
EA199800460A1 (ru) Диагностика и медиаторы воспалительных нарушений
WO2003042659A3 (en) Rapid prion-detection assay
WO1997012039A3 (en) Sh2-containing inositol-phosphatase
EA200101021A1 (ru) Способ диагностики трансмиссивных губчатых энцефалопатий
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
Trimpin et al. Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry
BR0206904A (pt) Métodos e dispositivos para quantificação de proteìna com glicato
Dong et al. “Stainomics”: identification of mitotracker labeled proteins in mammalian cells
WO2002099434A3 (de) Verwendung von 14-3-3-proteinen und verfahren zu deren bestimmung in flüssigkeiten oder geweben von organismen
WO2002016947A2 (en) Methods and kits for separation and detection of proteins in biological samples
AU2001287423A1 (en) Methods and kits for separation and detection of proteins in biological samples
ES2093026T3 (es) Procedimiento de ensayo de complementacion enzimatico de enlace e proteinas.
Hu et al. Chemical and Biochemical Strategies To Explore the Substrate Recognition of O‐GlcNAc‐Cycling Enzymes
ATE356865T1 (de) Untersuchungsverfahren für protein-protein- interaktion
Linse et al. Kinetic fingerprint of antibody therapies predicts outcomes of Alzheimer clinical trials